A Study to Assess the Effect of Seltorexant Compared to Placebo on Respiration During Sleep in Adult Participants With Obstructive Sleep Apnea

NCT03796026 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Sleep Apnea, Obstructive

Interventions

DRUG: Seltorexant 40 mg
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC